Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Solv Puts 100M+ Americans Within Reach Of A COVID-19 Vaccine In Preparation For Supply Surge to Meet National Herd Immunity Goals

- Solv Working with VaccineFinder.org to Connect People to Local Vaccination Sites with Vaccine Availability

- Solv for Vaccines Equips Health Departments to Ramp Up Multiple New Vaccination Sites and Start Booking High-Volume, High-Speed Appointments in Less Than a Week

- Solv Ready with Capacity to Book 100s of Thousands of Vaccine Appointments Daily in Anticipation of Expected Surge in Vaccine Availability


News provided by

Solv Health

Mar 23, 2021, 10:00 ET

Share this article

Share toX

Share this article

Share toX

SAN FRANCISCO, March 23, 2021 /PRNewswire/ -- Solv, the company making healthcare convenient for everyone, today announced that it has the capacity to put 100M+ Americans within a five mile radius of a same-day appointment for a COVID-19 vaccine. Solv is also partnering with public health departments across the country to spin up public-private partnerships to set up new vaccination sites and start booking high-volume appointments in less than a week in preparation for the anticipated surge in vaccine supply and the president's May 1 deadline for open vaccine eligibility.

Solv offers Solv for Vaccines, the most robust, reliable and consumer-friendly vaccine appointment scheduling system built on the Solv platform that has booked more than 28 million convenient care appointments, across all 50 states. Solv is currently working in partnership on high-volume COVID-19 vaccination efforts with more than 20 public health departments across six states, including counties in Michigan, Minnesota, New York, Pennsylvania, Texas and Washington, adding more partnerships each week to help the country meet aggressive goals for national herd immunity. Solv is working with VaccineFinder.org, the tool used by the CDC, to provide real-time vaccine appointment availability via the Solv app and online at www.solvhealth.com/covid-vaccine.

"We're coming out of a long winter of vaccine scarcity and our mental model has to change fast - from scarcity to surplus," said Heather Fernandez, co-founder and CEO of Solv. "We need to be thinking bigger and faster."

Fernandez continued, "We've seen incredible success when leaders make the shift in mindset. If we're mentally prepared to move quickly, there's no reason we can't get to the president's fourth of July goal. Possibly sooner. We are ready with the tools for a max vax world."

For the most vulnerable citizens in the US - the elderly, those with comorbidities, front line workers - the lack of supply and limited access to vaccines created a sense of fear, uncertainty, and even hopelessness. The uneven and disjointed vaccine rollout compounded feelings of anxiety for many Americans. The problem of vaccine scarcity, requiring precision distribution, is about to switch over to a problem of speed and volume, as vaccine supply comes online and eligibility is opened to the general population.

With the ability to connect 100M+ Americans across all 50 states to a same-day healthcare appointment within five miles, Solv has one of the largest networks in the nation for accessing convenient care. Solv's high=capacity scheduling system has already handled the administration of more than seven million COVID-19 tests and helps millions of patients connect to healthcare every month, reliably handled system traffic spikes up to 14x during peak COVID-19 testing season.

As vaccine supply surges in the coming weeks, the challenge will be to get doses in arms and avoid unnecessary delays - making it imperative to prepare now. Critical parts of this challenge include: vaccination sites adapting their schedules, making it easy for people to pre-register, understand when and where they can most easily get vaccinated, and move them through the process as quickly as possible.

Solv for Vaccines:

  • Speed: Set up multiple new vaccination sites simultaneously, in less than a week. Solv-powered sites can begin booking appointments in as little as four days. Patients can move through the vaccination process in as quickly as five minutes, with pre-registration and an advance check-in process.
  • Scale: On-demand vaccine appointment system reliably handles millions of patients each month. Solv simplifies vaccine site workflow, manages two-dose scheduling and books thousands of patients daily.
  • Access: Increases equitable access through easy vaccine scheduling options. Solv offers a simple patient user experience via phone, web or mobile app - no logins or downloads required. Provides efficient multi-dose vaccine scheduling and automated follow up reminders.

Solv's COVID-19 Response
Solv for Vaccines builds upon Solv's COVID-19 testing solution, which has been used to schedule more than 7 million COVID-19 tests to date and was instrumental in the effort to contain the coronavirus in Seattle. Thousands of hospital systems, government organizations, private practices, urgent care centers, and community pop-up sites have leveraged Solv technology to support their testing initiatives.

In December 2020, Solv began partnering with state and municipal health departments and the National Guard in individual states, to quickly ramp up COVID-19 vaccination efforts across the country, with the capacity to manage appointments for hundreds of thousands of patients a day once vaccine supply is available. In January 2021 Solv announced the availability of Solv for Vaccines and as of March 2021, Solv is rolling out high-volume, high-speed vaccination sites in partnership with more than twenty public health departments from coast to coast.

ABOUT SOLV
Solv is making healthcare convenient for everyone, providing consumer-friendly options via the web and Solv app to connect people with same-day health appointments virtually or with a local provider. The Solv platform is provider-friendly, partnering with high-quality physicians across the country to deliver a modern, magical patient experience by answering consumer's three everyday health questions: Where should I go? Who should I see? How much will it cost? More than 28 million health appointments have been booked through Solv.

Download the Solv app or book online at solvhealth.com
Providers can learn more at solvhealth.com/for-providers

SOURCE Solv Health

Related Links

http://www.solvhealth.com

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.